| 注册
首页|期刊导航|中国临床药理学杂志|Th17/Treg细胞与高血压相关性的研究现状

Th17/Treg细胞与高血压相关性的研究现状

龚玉栓 王倩 魏惠平

中国临床药理学杂志2024,Vol.40Issue(20):3056-3060,5.
中国临床药理学杂志2024,Vol.40Issue(20):3056-3060,5.DOI:10.13699/j.cnki.1001-6821.2024.20.030

Th17/Treg细胞与高血压相关性的研究现状

Research status of the relationship between Th17/Treg cells and hypertension

龚玉栓 1王倩 1魏惠平2

作者信息

  • 1. 甘肃中医药大学中西医结合学院,甘肃兰州 730000
  • 2. 甘肃中医药大学附属医院心血管科,甘肃兰州 730020
  • 折叠

摘要

Abstract

Hypertension is a common chronic disease,and its incidence is increasing year by year worldwide.Its pathological mechanism is complex,involving genetics,environment,lifestyle and other factors.In recent years,the role of immune-inflammatory mechanism in the pathogenesis of hypertension has gradually attracted attention.Especially T helper cell 17(Th17)and regulatory T cells(Treg),as important components of the immune system,the effect of their balance on hypertension has become a research hotspot.This article reviews the research progress of the correlation between Th17/Treg and hypertension,in order to provide new ideas and methods for the immunotherapy and prevention of hypertension.

关键词

辅助性T细胞17/调节性T细胞/高血压

Key words

T helper cell 17/regulatory T cell/high blood pressure

分类

药学

引用本文复制引用

龚玉栓,王倩,魏惠平..Th17/Treg细胞与高血压相关性的研究现状[J].中国临床药理学杂志,2024,40(20):3056-3060,5.

基金项目

甘肃省自然科学基金资助项目(21JR7RA581) (21JR7RA581)

甘肃省中医药管理局课题资助项目(GZKZ-2020-9) (GZKZ-2020-9)

甘肃中医药大学附属医院院内创新基金资助项目(KC2018-18) (KC2018-18)

中国临床药理学杂志

OA北大核心CSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文